Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indapamide/Losartan vs Hyzaar in Hypertension
NCT01620788Phase 3Suspended
- Sponsor
- EMS
- Start
- Nov 2019
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of indapamide in hypertension (HTN), sponsored by EMS. Started Nov 2019; status: suspended.
02
Drugs
indapamide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01620788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01620788.